Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | RAB9A | P51151 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 3/20 | 1.00 |
| ▸ | THPO | P40225 | 3/20 | 1.00 |
| ▸ | GMNN | O75496 | 3/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | MTOR | P42345 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | PPM1B | O75688 | 2/20 | 1.00 |
| ▸ | PPP1CC | P36873 | 2/20 | 1.00 |
| ▸ | TFPI2 | P48307 | 2/20 | 1.00 |
| ▸ | PPP5C | P53041 | 2/20 | 1.00 |
| ▸ | PPP1CA | P62136 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cantharidin SCHEMBL152261 | 1.00 | MAPK1 (1.00) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| Cantharidin SCHEMBL152262 | 1.00 | MAPK1 (1.00) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| Cantharidin SCHEMBL14120808 | 1.00 | MAPK1 (1.00) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL20885000 | 0.84 | MAPK1 (0.71) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL24129015 | 0.81 | MAPK1 (0.67) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL19619602 | 0.81 | MAPK1 (0.67) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL20618517 | 0.78 | MAPK1 (0.62) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL23080410 | 0.75 | TP53 (0.57) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL3496407 | 0.74 | MAPK1 (0.59) | MAPK1TP53LMNASMN1; SMN2RAB9A | |
| SCHEMBL14025795 | 0.73 | MAPK1 (0.57) | MAPK1TP53LMNASMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119374-A | UV-cured high-temperature-resistant resin for thermal runaway protection material and application | 武汉长盈鑫科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2010-06-03 | — | — | US | claimed |
| EP-2086534-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | Genetic Technologies Limited (AU) | 2009-08-12 | — | — | EP | claimed |
| WO-2008058342-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | GENETIC TECHNOLOGIES LIMITED (AU) | 2008-05-22 | — | — | WO | claimed |
| EP-4339199-B1 | SYNTHESIS OF CANTHARIDIN | VERRICA PHARMACEUTICALS INC (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12522724-B2 | Polymer, dispersion, and paint | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2026-01-13 | — | — | US | disclosed |
| CN-223347303-U | Automatic power input switching circuit of server BMC | 深圳算界先峰信息科技有限公司 | 2025-09-16 | — | — | CN | disclosed |
| CN-120059033-A | Polymer and coating | 财团法人工业技术研究院 | 2025-05-30 | — | — | CN | disclosed |
| US-20250171643-A1 | POLYMER AND COATING MATERIAL | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2025-05-29 | — | — | US | disclosed |
| EP-4556561-A1 | EXPRESSION OF BIOMOLECULES WITH IMPROVED PROMOTER AND TIR | CysBio ApS (DK) | 2025-05-21 | — | — | EP | disclosed |
| CN-114514340-B | Differential contrast plating for advanced packaging applications | 朗姆研究公司 | 2025-03-21 | — | — | CN | disclosed |
| US-12221452-B2 | Synthesis of cantharidin | VERRICA PHARMACEUTICALS INC. (US) | 2025-02-11 | — | — | US | disclosed |
| US-20090124558-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURAL ANOXIA AND SPREADING DEPRESSION | FLORIDA ATLANTIC UNIVERSITY (US) | 2009-05-14 | — | — | US | disclosed |
| WO-2009046322-A2 | COMPOSITIONS AND METHODS FOR TREATING NEURAL ANOXIA AND SPREADING DEPRESSION | FLORIDA ATLANTIC UNIVERSITY (US) | 2009-04-09 | — | — | WO | disclosed |
| US-20080004440-A1 | SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS | BIOBOTANIC CORP. (US) | 2008-01-03 | — | — | US | disclosed |
| US-20080004440-A1 | SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS | BIOBOTANIC CORP. (US) | 2008-01-03 | — | — | US | disclosed |
| US-20080004440-A1 | SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS | BIOBOTANIC CORP. (US) | 2008-01-03 | — | — | US | disclosed |
| WO-2007149543-A2 | SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS | BIOBOTANIC CORP. (US) | 2007-12-27 | — | — | WO | disclosed |
| WO-2007149543-A2 | SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS | BIOBOTANIC CORP. (US) | 2007-12-27 | — | — | WO | disclosed |
| US-20070184044-A1 | Thermoprotective compositions of PKG pathway inhibitors and method of use thereof | DAWSON-SCULLY KENNETH | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137294-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING INVERTEBRATE PESTS | PPP1R10, TASP1, PPP5C | MAPK1 812/4885TP53 1847/4885LMNA 4332/4885 |
| US-12221452-B2 | Synthesis of cantharidin | TYR, CMA1, DPM1 | MAPK1 1592/4885TP53 3315/4885LMNA 4280/4885 |
| US-20080004440-A1 | SCAR TREATMENT USING PROTEIN PHOSPHATASE INHIBITORS | PPP3CA, PTPA, PPP5C | MAPK1 1502/4885TP53 1882/4885LMNA 3561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.